Sort   by:  
 Page size 
UnknownProtection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Not available
S-EPMC10187514 | biostudies-literature
UnknownAntibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
Not available
S-EPMC8294260 | biostudies-literature
UnknownAntibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Not available
S-EPMC9117148 | biostudies-literature
UnknownImproving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.
Not available
S-EPMC11196632 | biostudies-literature
UnknownSARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Not available
S-EPMC9243074 | biostudies-literature
UnknownTracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
Not available
S-EPMC8693687 | biostudies-literature
UnknownRelevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Not available
S-EPMC3163848 | biostudies-literature
UnknownEffect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Not available
S-EPMC3254252 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
Sort   by:  
 Page size